Purpose: To evaluate corneal morphology using ultrasonic pachymetry (USP), Fourier-domain optical coherence tomography (FD-OCT), and in vivo confocal microscopy (IVCM) in 2 related canine breeds-German shorthaired pointers (GSHPs) and German wirehaired pointers (GWHPs)-with and without corneal endothelial dystrophy (CED). This condition is characterized by premature endothelial cell degeneration leading to concomitant corneal edema and is similar to Fuchs endothelial corneal dystrophy.
F
uchs endothelial corneal dystrophy (FECD) is a common, late-onset condition in humans characterized by progressive loss of endothelial cells and formation of guttae or collagenous deposits on Descemet membrane (DM). With progressive loss of endothelial cells, a point is reached where the remaining cells are unable to maintain stromal deturgescence 1 leading to secondary thickening of the cornea from edema and loss of corneal transparency, decreased visual acuity, and bullous keratopathy. 2 Similar to patients with FECD, adult dogs have a bilateral, sometimes asymmetric, disease in which endothelial cells degenerate prematurely, termed corneal endothelial dystrophy (CED). With canine CED, corneal endothelial decompensation can occur with concomitant corneal edema and secondary vision compromise, bullous keratopathy, and corneal ulceration. 3, 4 Multiple breeds seem to be at an increased risk for CED, particularly in small breed dogs such as Boston terriers, Chihuahuas, and dachshunds, an observation that suggests an underlying genetic component for this disease in dogs. 4, 5 In reviewing the records at the University of CaliforniaDavis Veterinary Medical Teaching Hospital, we identified that 2 large breed dogs, German shorthaired pointers (GSHP) and German wirehaired pointers (GWHP), were overrepresented compared with the hospital reference population (unpublished data). To the authors' knowledge, CED has been only rarely described in large canine breeds 6 and never been described or characterized in these 2 closely related breeds. Thus, the purpose of this study was to describe and characterize CED in GSHPs and GWHPs using noninvasive advanced ophthalmic imaging techniques and histopathology.
MATERIALS AND METHODS

Animals
The study was performed in accordance with the Association for Research in Vision and Ophthalmology resolution on the use of animals in research and was approved by the Institutional Animal Care and Use Committee at University of California-Davis (#17847). All dogs included were GSHPs or GWHPs; none had received medications for at least 48 hours before study inclusion. For unaffected dogs, criteria for inclusion were clear corneas in both eyes and regular arrangement of corneal endothelial cells with in vivo confocal microscopy (IVCM). For CED-affected dogs, criteria for inclusion were the presence of corneal edema in both eyes. For both groups, criteria for exclusion were diabetes mellitus, previous intraocular surgery or history and/or clinical signs consistent with glaucoma, anterior uveitis, and/or lens instability.
An ophthalmic examination was performed including digital and handheld slit-lamp biomicroscopy (Imaging Module 900; Haag-Streit USA Inc, Mason, OH; SL-15, Kowa Company Ltd, Nagoya, Aichi, Japan). A Schirmer Tear Test-1 (STT-1; Intervet Inc, Summit, NJ) was performed followed by measurement of corneal sensitivity with a Cochet-Bonnet esthesiometer (12/100 mm, Luneau Ophtalmologie, Prunayle-Gillon, France) using previously described methods. 7 Proparacaine 0.5% ophthalmic solution (Akorn Inc, Lake Forest, IL) was applied before performing applanation tonometry (Tono-Pen XL; Mentor Ophthalmics, Norwell, MA) to measure intraocular pressure (IOP). Ultrasonic pachymetry (Pachette 3; DGH Technology Inc, Exton, PA) was performed as previously described. 5 Dogs were sedated with acepromazine (0.01 mg/kg) and buprenorphine (0.01 mg/kg) administered intravenously.
Ophthalmic Imaging
Animals were placed in sternal recumbency. Fourierdomain optical coherence tomography (FD-OCT) imaging (RTVUE 100; software version 6.1; Optovue Inc, Fremont, CA; 26,000 A scan/sec, 5-mm axial resolution, 840-nm superluminescent diode) of the central cornea was performed as previously described. 8 Next, IVCM (ConfoScan 4; Nidek Technologies, Gamagori, Japan) was performed in the central cornea with a ·40/0.75 objective lens as previously described. 9 To determine density of keratocyte and endothelial cells, a region of interest of 0.075 and 0.05 mm 2 was used, respectively. Last, corneas were stained with fluorescein sodium (Ful-Glo strips USP 1 mg; Akorn Inc).
Owner Survey
A survey was conducted with each client who had a dog enrolled in the study (see Table, Supplemental Digital Content 1, http://links.lww.com/ICO/A592). This survey was reviewed by the UC Davis Institutional Review Board and was deemed exempt.
Histopathology
One 14-year-old intact female CED-affected GSHP and one unaffected 15-year-old intact male GSHP were euthanized for reasons unrelated to their eyes; owner consent was obtained in accordance with hospital policy for use of tissues after being euthanized. The right globe from each dog was enucleated, placed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 5 mm, and stained with hematoxylin and eosin or periodic acid-Schiff. The sections were examined by a boardcertified veterinary pathologist (C.M.R.).
Statistical Analysis
For all measurements, values from each eye were averaged. A Student t test was used to compare age, weight, epithelial thickness, endothelial-DM complex thickness, keratocyte density, endothelial density, STT-1 values, and IOP between CED-unaffected and affected dogs and age and weight between GSHPs and GWHPs; a Fisher exact test was used to compare the sex distribution between groups. Kruskal-Wallis 1-way analysis of variance on ranks was used to compare differences in total corneal thickness between CED-unaffected and affected dogs by location. A Mann-Whitney rank-sum test was used to compare central corneal thickness (CCT), stromal thickness, corneal touch threshold, and time spent outdoors between CED-unaffected and affected dogs. Least squares linear regression assessed the relationship between central epithelial thickness and CCT. Data are presented as mean 6 SD or median (range).
RESULTS
Study Population
The corneas of 10 affected (4 GSHP and 6 GWHP) and 19 unaffected (15 GSHP and 4 GWHP) dogs were included; 3 affected GWHPs were from the same litter. The sex distribution did not significantly differ between the affected (4 females and 6 males) and unaffected (9 females and 10 males) groups (P = 1). Mean age and weight did not significantly differ between CED-affected and unaffected dogs at 11.0 6 1.9 and 28 6 4.0 kg and 10.7 6 1.8 years and 28 6 5.8 kg, respectively (P = 0.729 and 0.737, respectively). Mean age and weight did not significantly differ between GSHPs and GWHPs at 10.8 6 1.9 years and 27 6 4.8 kg and 10.9 6 1.7 years and 30 6 5.5 kg, respectively (P = 0.88 and 0.112, respectively). Accordingly, data from both breeds were combined for all analyses.
Ultrasonic Pachymetry
The CED-unaffected dogs had central, superior, inferior, nasal, and temporal perilimbal corneal thicknesses of 646 (497-737), 708 (620-799), 663 (539-738), 669 (555-803), and 690 (592-795) mm, respectively, which significantly differed at all locations (P , 0.005, Fig. 1 ) but the inferior and nasal cornea (P = 0.224). CED-affected dogs had significantly thicker corneas at all locations versus unaffected dogs with central, superior, inferior, nasal, and temporal perilimbal measurements of 1179 (953-1959), 1289 (955-1725), 1098 (898-1805), 1146 (938-1612), and 1198 (1039-1629) mm, respectively (P , 0.001); there were no significant differences in corneal thickness between locations (P . 0.05, Fig. 1 ).
Fourier-Domain Optical Coherence Tomography
In CED-affected dogs, corneal thickening was caused by edema with loss of the orderly arrangement of collagen in the corneal stroma and the increase in reflectivity as observed by multiple imaging modalities (Fig. 2) . Consistent with ultrasonic pachymetry (USP), CCT as measured by FD-OCT, significantly differed between CED-affected and unaffected dogs (P , 0.001, Fig. 3A ). The increase in CCT was primarily due to a significant increase in stromal thickness in CED-affected versus unaffected dogs (P , 0.001, Fig. 3A) . Thickness of the DM-endothelium complex was significantly greater in CED-affected versus unaffected dogs (P = 0.003, Fig. 3B ). By contrast, central epithelial thickness was significantly less in CED-affected and unaffected dogs (P = 0.011, Fig. 3B ). A decrease in central epithelial thickness significantly correlated with CCT (P = 0.049, R 2 = 0.141, Fig. 3C ).
In Vivo Confocal Microscopy
With IVCM, marked differences in endothelial cell morphology were identified with a regular, hexagonal pattern in unaffected dogs and pleomorphism and polymegethism in 5 CED-affected dogs that varied depending on their disease severity; severe corneal edema prevented visualization of the endothelium in the 5 remaining dogs. Endothelial cell density (ECD) was significantly less in CED-affected (n = 5) versus unaffected (n = 19) dogs (P , 0.001, Fig. 4 ). In the anterior and posterior stroma, keratocyte density did not differ significantly (P = 0.162 and 0.684, respectively) in dogs with CED (n = 3) at 394 6 73 and 424 6 77 cells/mm 2 versus unaffected controls (n = 19) at 464 6 77 and 442 6 71 cells/ mm 2 . Severe corneal edema prevented visualization of keratocytes in 6 CED-affected dogs.
Ancillary Diagnostic Tests
Aqueous tear production, central corneal touch threshold, and IOP did not significantly differ between affected and unaffected dogs at 22 6 2.7 mm/min, 3.95 (2.3-13.1) g/mm 2 and 8.3 (4.5-17) mm Hg and 21 6 2.7 mm/ min, 3.4 (1.4-13.1) g/mm 2 and 7.0 (4-11.5) mm Hg, respectively (P = 0.617, 0.466, and 0.581, respectively). No dogs had corneal fluorescein retention at the examination.
Owner Survey
Owners of 28 of the 29 dogs (97%) included in this study completed the survey, with the one unanswered survey from the owner of an affected GWHP. Ophthalmic conditions reported by owners included CED (n = 8), meibomian gland adenoma (n = 1), and retrobulbar mass (n = 1). In the CEDaffected dogs, median (range) age at onset of clinical signs was 10 (6-12) years. Time outdoors did not significantly differ between CED-affected and unaffected dogs with a median (range) of 3 to 6 (1-2 to .12) and 1 to 2 (1-2 to .12) hours, respectively (P = 0.177). Of the 10 affected dogs, 6 had previously received treatment of CED. At initiation of treatment, severity of clinical signs was median (range) of 7.5 (3-10) for 6 dogs. Five affected dogs were topically treated with 5% sodium chloride (NaCl) ophthalmic ointment and a medication containing a corticosteroid. One dog was treated solely with an antibiotic-steroid solution. Four owners reported that topical 5% NaCl with a corticosteroid was the most effective treatment, one owner did not indicate a most effective treatment, and one owner reported that the patient did not improve on any medical therapies. Four owners indicated severity of clinical signs after medical therapy with a median (range) of 6 (3.5-7). Three of the patients with submitted surveys had received surgical intervention, a superficial keratectomy and conjunctival advancement hood flap (SKCAHF), for their disease. 10 In these 3 patients, owner-reported disease severity was 8 and 7 before surgery and 2 and 5.5 after surgery, respectively; one owner did not rate disease severity with regard to surgery. Ultrasonic pachymetry, FD-OCT, and IVCM data were available and included for 2 dogs before SKCAHF surgery, whereas only central USP data were available for 1 dog and were included before SKCAHF surgery. One GSHP included in this study that received SKCAHF surgery was described in a separate publication. 10 
Histopathology
In the dog with CED, DM was slightly thicker with guttae-like protrusions of disorganized, fibrillar extracellular matrix (ECM), compared with smooth and uniform DM in the CED-unaffected dog (Fig. 5) . Corneal endothelial cells were flattened, attenuated, and much less frequent along the inner aspect of DM in the CED-affected versus unaffected dog (Fig. 5) .
DISCUSSION
The results of this study demonstrate numerous clinical and histologic similarities between canine CED and human FECD. Other human endothelial disorders such as congenital hereditary endothelial dystrophy, X-linked endothelial corneal dystrophy, and posterior polymorphous corneal dystrophy are inconsistent with canine CED given the adult onset, affected females, and specific morphology in DM and the endothelium observed. 4, 5, 11 Using IVCM, marked morphologic changes were observed in CED-affected dogs, including polymegethism and pleomorphism, which tended to increase in correlation with disease severity. Microscopically, endothelial cell morphology was markedly attenuated and spread with a decrease in density in a CED-affected versus unaffected dog consistent with a previous study documenting fibrous metaplasia in canine CED. 4 FIGURE 2. Corneal structure and endothelial morphology as determined by color photography, digital slit-lamp biomicroscopy, FD-OCT, and IVCM dramatically differed between control and CED-affected dogs with variable disease severity. A 14-year-old spayed female GSHP with a clear cornea (A1-2), normal corneal thickness and lamellar arrangement of the collagen fibrils (A3), and regular, hexagonal arrangement of the corneal endothelium (A4); this dog was categorized as a control. An 11-year-old intact male with mild diffuse corneal edema (B1-2), a mildly thickened cornea (B3), and moderate pleomorphism and polymegethism of the corneal endothelium (B4); an 8-year-old spayed female GSHP with moderate diffuse edema of the cornea (C1-2), increased corneal thickness (C3), and moderate pleomorphism and polymegethism of the corneal endothelium (C4); a 13-year-old spayed female GSHP with marked, diffuse corneal edema (D1-2), a marked increase in corneal thickness (D3), and loss of the orderly arrangement of collagen fibrils within the anterior stroma (D3-4) such that the corneal endothelium and keratocytes could not be visualized (D4).
Similarly, endothelial cells undergo epithelial-mesenchymal transformation in FECD and exhibit a fibroblast-like phenotype, 12 which suggests that epithelial-mesenchymal transformation may play an important role in the pathophysiology of both diseases. 13 Furthermore, ECD was markedly decreased in CED-affected GSHPs and GWHPs versus age-matched controls and less than previously reported values in CED-affected Boston Terriers. 5 Interestingly, ECD was also lower in normal adult GSHPs and GWHPs in comparison to previous reported values in normal adult dogs 14 and Boston Terriers. 5 It is possible that large breed dogs such as GSHPs and GWHPs have lower ECD and/or accelerated endothelial cell loss compared with small breed dogs such as Boston terriers. It is well known that large breed dogs age faster and die earlier than small breed dogs, 15 and a decline in ECD is expected with aging. Thus, endothelial decompensation from CED may occur at an earlier age in GSHPs and GWHPs and possibly other large canine breeds. Further studies of ECD and body weight over time in normal and CED-affected dogs are warranted.
Numerous studies have documented that DM is markedly thicker in patients with versus without FECD using a variety of techniques. 16, 17 We similarly demonstrated with FD-OCT that the DM-endothelium complex was significantly thicker in CEDaffected dogs in the present and a previous study. 5 Furthermore, histology demonstrated thickened DM with a posterior fibrillar layer and guttae-like deposits in a GSHP with CED consistent with a previous study. 4 A prominent feature of FECD is the formation of guttae or excrescences of ECM on DM that is often observed with IVCM, 18 which suggests that this dysregulated DM may play an important role in disease progression. 19 Therefore, studying the pathogenesis of canine CED may offer new insight into FECD that animal models of endothelial injury would not provide.
Mean CCT of unaffected GSHPs and GWHPs is 614 mm, which is greater than that of 527 mm reported in patients aged 60 years or older. 20 CCT increases with body weight; thus, small breed dogs such as beagles 8 and Boston terriers 5 will have CCT closer to a human versus large canine breeds. In CEDaffected dogs, 5 endothelial decompensation results in a marked increase of CCT because of moderate to severe corneal edema. By contrast, humans with FECD tend to have a mild increase in CCT from corneal endothelial decompensation presumably because of patients with FECD seeking ophthalmic care at an earlier disease stage from decreased visual acuity 2 versus owners of CED-affected dogs. 3, 21 Intrinsic differences between the human and canine corneas exist including less extensive collagen fiber intertwining in the canine (unpublished data, M. Winkler, J. V. Jester, UC Irvine, S. M. Thomasy, V. K. Raghunathan, C. J. Murphy, UC Davis) versus human corneas 22 and a lack of the Bowman layer 23 in the dog, which would make the canine cornea more susceptible to swelling. Interestingly, the central corneal epithelium was significantly thinner in CED-affected versus unaffected GSHPs and GWHPs consistent with a previous study. 5 This finding in combination with formation of corneal bullae likely contributes to the tendency for these dogs to ulcerate and thus experience ocular discomfort. 24 Although it is possible that a thinner epithelium is intrinsic to canine CED, it is more likely related to corneal edema given the inverse linear relationship between CCT and FIGURE 3. Central corneal full, stromal, epithelial, and DMendothelium complex thickness significantly differed between dogs without and with CED as measured by FD-OCT. CCT was significantly greater in 9 CED-affected versus 19 unaffected dogs with a median (range) of 1100 (910-1755) and 614 (506-677) mm, respectively, primarily because of a significant increase in stromal thickness in CED-affected versus unaffected dogs at 1009 (831-1705) and 539 (442-591) mm, respectively (A). Epithelial thickness in the central cornea was significantly less in dogs with versus without CED at 47 6 7.1 and 55 6 7.1 mm, respectively (B). In the central cornea, DMendothelium complex thickness was significantly greater in dogs with versus without CED at 36 6 6.3 and 29 6 4.5 mm, respectively. Box plots depict median (solid line), mean (dashed line), and 25th and 75th percentiles, whereas whiskers show 10th and 90th percentiles; black circles indicate outliers. The P values were determined by a Mann-Whitney rank-sum test, *P , 0.05, **P , 0.01, and ***P , 0.001. C, A significant inverse relationship was identified between epithelial thickness and CCT as measured by FD-OCT using least squares linear regression (P = 0.049, R 2 = 0.141).
epithelial thickness observed. To the authors' knowledge, a difference in epithelial thickness between patients with or without FECD has not been studied, but investigations may be warranted given the present findings.
Corneal edema in CED-affected GSHPs or GWHPs was predominantly diffuse and contrasts with CED-affected Boston terriers where edema typically begins temporally and progresses to involve the entire cornea, affecting the nasal aspect last. [3] [4] [5] In humans, even mild, diffuse corneal edema can result in a marked decrease in visual acuity 2 ; thus, GSHPs and GWHPs may experience a decline in vision earlier than Boston terriers with temporal edema that does not affect the visual axis. Penetrating keratoplasty is the gold standard treatment of canine CED 3 but is rarely performed because of a high risk of complications, lack of appropriate donor tissue, and high cost of surgery to owners. Other interventions to treat CED include SKCAHF, 10 thermokeratoplasty, 21 penetrating or nonpenetrating keratoprosthesis, 25, 26 and corneal crosslinking with riboflavin and ultraviolet light. 27 In the present study, 3 dogs received a SKCAHF with moderate to marked improvement noted by 2 owners; the third owner did not complete this portion of the survey. These results are consistent with a recent clinical trial whereby owners reported increased corneal clarity and vision in their dogs after SKCAHF surgery. 10 The most common palliative treatment was 5% NaCl, which is consistent with previous reports of CED-affected dogs. 28 Four owners reported worsening (n = 1), no (n = 1), or mild to moderate (n = 2) improvement with 5% NaCl consistent with a previous study demonstrating only a 2% decrease in corneal thickness after at least 4 times of daily treatment with this medication in normal dogs. 28 There are numerous advantages to a spontaneous, large animal model for FECD. CED in dogs occurs spontaneously and thus is more likely to mimic the genetic and environmental variability within the human population, especially when compared with the highly inbred and uniform environment of laboratory animals. 29 Dogs are commonly used in ocular drug development and to investigate and develop treatments for corneal disease because of their large eyes, ease of handling, and relatively similar corneal anatomy to humans. [30] [31] [32] There are well-characterized murine FECD models, Col8a2 L450W/ L450W and Col8a2 Q455K/Q455K , which exhibit guttae, decreased ECD, and altered endothelial cell morphology, 33 but these models have limited value for investigating surgical and Endothelial cell density could not be assessed in 5 dogs with CED because of severe, bilateral corneal edema. Box plots depict median (solid line), mean (dashed line), and 25th and 75th percentiles, whereas whiskers show 10th and 90th percentiles; black circles indicate outliers. The P value was determined by a Students t test, ***P , 0.001. FIGURE 5. Histology morphology of the corneal endothelium and DM markedly differed between a dog with and without CED. Photomicrographs of sections of the inner cornea from the right eye of a 15-year-old intact male GSHP (A and B) unaffected with CED and a 14-year-old intact female CED-affected GSHP (C and D) stained with hematoxylin and eosin (·200 magnification) or periodic acid-Schiff (·400 magnification) where DM is bright magenta, respectively. A and B, Note the smooth contour of the inner aspect of DM (*), and the frequent nuclei in the cuboidal endothelial cells (example at the arrowhead) in a dog unaffected with CED. In the CED-affected dog (C), note the irregularities (arrows) on the inner surface of DM (*) and the slight increase in thickness of DM compared with the CED-unaffected dog (A). The endothelium is more sparsely cellular, and the cells are attenuated (example at the arrowhead) in the CED-affected (C) versus unaffected dog (A). In D, note the pale-staining guttae-like excrescences of loose, fibrillar ECM (arrows) on the inner surface of DM (magenta) in the CED-affected dog; 2 of these excrescences are associated with flattened endothelial cells (examples at arrowheads). In D, DM (*) is also slightly thicker than in B (CED-unaffected).
cell-based interventions because of the small murine eye. Additionally, a large discrepancy exists between murine and human CCT likely contributing to great variability in the kinetics of topical ocular drug delivery between the 2 species. 34, 35 Veterinary clinical trials of CED-affected patients may thus provide a more predictive model for evaluation of pharmacologic, surgical, and cell-based therapies for human FECD from preclinical development to human clinical trials. 29 In conclusion, this study used advanced ophthalmic imaging to describe the in vivo characteristics of CED in 2 closely related breeds-the GSHP and GWHP. Similar to FECD, CED is a bilateral, adult-onset condition that exhibits endothelial cell loss concurrently with abnormal DM. Thus, CED could serve as a useful disease model to study the pathogenesis, progression, and novel therapies for FECD.
